首页> 美国卫生研究院文献>Neurointervention >Protection of Personal Information in Medical Journal Publications
【2h】

Protection of Personal Information in Medical Journal Publications

机译:医学期刊出版物中的个人信息保护

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It aimed to present the definition of personal information based on Korean laws that protect personal information and the process of protection of personal information in journal publishing based on the guidelines of the International Committee of Medical Journal Editors and Committee of Publication Ethics. Two Korean laws relate to the protection of personal information in human subject research: the Personal Information Protection Act and the Bioethics and Safety Act. These laws were enacted to prevent the unauthorized use of Koreans’ personal information including medical information. Personal information can be divided into personally identifiable information including resident registration numbers and sensitive information including health information. To protect personal information in journal publishing, institutional review board (IRB) approval and obtaining informed consent from patients is recommended or mandatory in clinical studies. However, retrospective chart reviews may be exempted from IRB approval, while obtaining informed consent is recommended for all case reports. Journal policies may vary with regard to whether a copy of the informed consent form is collected from authors, since the Committee of Publication Ethics guideline does not specifically recommend collecting it. In discussions of adopting clinical data-sharing policies, transfer of data including nonidentifiable personal information to another country is an unresolved issue. Furthermore, a public data repository site should be established in Korea for data to be deposited. To protect subjects’ privacy and to prevent legal issues potentially arising from privacy concerns, editors and publishers should do their best to publish articles with appropriate oversight on subjects’ personal information.
机译:它旨在根据国际医学期刊编辑委员会和出版道德委员会的指南,根据保护个人信息的韩国法律提出个人信息的定义,以及在期刊出版中保护个人信息的过程。韩国的两项法律与人类受试者研究中的个人信息保护有关:《个人信息保护法》和《生物伦理与安全法》。制定这些法律是为了防止未经授权使用韩国人的个人信息(包括医疗信息)。个人信息可以分为包括居民登记号在内的个人身份信息和包括健康信息在内的敏感信息。为了保护期刊出版中的个人信息,在临床研究中建议或强制执行机构审查委员会(IRB)的批准并征得患者的知情同意。但是,回顾性图表审查可以免除IRB的批准,同时建议所有病例报告均获得知情同意。关于是否从作者那里收集知情同意书的副本,期刊政策可能会有所不同,因为出版道德委员会指南并不特别建议您收集它。在讨论采用临床数据共享政策时,将包括无法识别的个人信息的数据传输到另一个国家是一个未解决的问题。此外,应该在韩国建立一个公共数据存储站点以存放数据。为了保护主题的隐私并防止可能因隐私问题引起的法律问题,编辑和发布者应尽力在适当监督主题的个人信息的情况下发布文章。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号